A comprehensive biomanufacturing center solving bottlenecks in cell and gene therapy manufacturing to accelerate new therapies for California patients

Return to Grants

Grant Award Details

Grant Number:
INFR5-14636
Investigator(s):
Type:
PI

Award Value:
$2,000,000
Status:
Active

Grant Application Details

Application Title:

A comprehensive biomanufacturing center solving bottlenecks in cell and gene therapy manufacturing to accelerate new therapies for California patients

Public Abstract:
We aim to considerably expand access for all Californians to outstanding cell and gene therapy treatments for multiple patients. With operational enhancements to develop diverse talent from underserved communities, our GMP facility will advance all aspects of biomanufacturing within the network.
Statement of Benefit to California:
As part of the Cell and Gene Therapy (CGT) Manufacturing Network, we will bring operational enhancements and workforce development programs to advance and alleviate constrained biomanufacturing capabilities in California. Such advances will allow us to manufacture latest CGT treatments for multiple patients with debilitating diseases and unmet needs. Californians with devastating diseases will have access to CGT products manufactured in our GMP facility for early and later stage clinical trials.